header

Program

 

Wednesday November 11, 2015

 

16.00-17.30

Registration (MECC)

 
 

17.30-18.00

Public transport to City Hall

 
 

18.00-19.00

Welcome Reception by the City of Maastricht  (City Hall)

 

19.00-22.00

Speakers dinner

 
     
     

 

Thursday November 12, 2015
Basic Cancer Epigenetics

 
 

09.00-09.15

Opening: Prof. Manon van Engeland (NL)

 

09.15-10.00

Decoding regulatory landscapes in human and fly cancer - Prof. Stein Aerts (BE)

 
 

10.00-10.30

Coffee/tea break

 
 

 

Chair: Linda Bosch

 

10.30-11.15

Progressive epigenetic programming during B cell maturation yields a continuum of disease phenotypes in chronic lymphocytic leukemia - Prof. Christoph Plass (DE)

 
 

11.15-11.30

A mixture model for the omics based identification of loci featured by monoallelic epigenetic modifications or expression and their deregulation in cancer - Tine Goovaerts (BE)

 

11.30-11.45

Methylation of hypoxia genes in cervical cancer - Cathinka Julin (N)

 

11.45-12.00

Embryonic stem cell (ES)-specific enhancers specify the expression potential of ES genes in cancer - Asaf Hellman (IL)

 

12.00-13.00

Lunch break

 
 

 

Chair: Bieke Decaesteker

 

13.00-13.45

Epigenetics and Epigenomics in Cancer - Prof. Francois Fuks (BE)

 
 

13.45-14.30

TET proteins, 5-methylcytosine oxidation and cancer - Dr. Anjana Rao (USA)

 
 

14.30-15.00

Coffee/tea break

 
 

15.00-17.00

Poster session

 
 

17.00-18.00

Public transport/walking to Ipanema, Congress dinner

 
 

18.00-22.00

Congress dinner

 
 
     
     

 

Friday November 13, 2015
Translational Cancer Epigenetics

 
 

09.00-10.15

Meet the experts breakfast; Interactive breakfast with the world leaders in this field (Keynote speakers)!

 
 

 

Chair: Vera Kloten

 

10.15-11.00

Moving from epigenomics to epigenetic targets - Prof. James Herman (USA)

 
 

11.00-11.45

The Cancer Epigenome - Dr. Peter Jones (USA)

 
 

11.45-12.15

Coffee/tea break

 

 

Chair: Felix Bormann

 

12.15-12.30

Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion positive versus negative tumors - Milan Geybels (USA)

 

12.30-12.45

Dysregulation of TET1 and hydroxymethylation in high-risk prostate cancer - Elien Smeets (BE)

 

12.45-13.00

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers - Jana Jeschke (BE)

 

13.00-14.15

 Lunch break

 
 

 

Chair: Tim de Ruijter

 

14.15-15.00

Epigenetic changes associated with colon cancer formation - Prof. Frank Lyko (DE)

 
 

15.00-15.45

Isolation, identification and the functional study of LncRNA-R54 in human colorectal cancer - Prof. Mingzhou Guo (CN)

 
 

15.45-16.15

Closing: Prof. Francois Fuks (BE)

 
 

16.15

Farewell and departure

 
 
spacer